Literature DB >> 26539838

Breast Cancer beyond the Age of Mutation.

Mark A LaBarge1, E Lorena Mora-Blanco, Susan Samson, Masaru Miyano.   

Abstract

Age is the greatest risk factor for breast cancer, but the reasons underlying this association are unclear. While there is undeniably a genetic component to all cancers, the accumulation of mutations with age is insufficient to explain the age-dependent increase in breast cancer incidence. In this viewpoint, we propose a multilevel framework to better understand the respective roles played by somatic mutation, microenvironment, and epigenetics making women more susceptible to breast cancer with age. The process of aging is associated with gradual breast tissue changes that not only corrupt the tumor-suppressive activity of normal tissue but also impose age-specific epigenetic changes that alter gene expression, thus reinforcing cellular phenotypes that are associated with a continuum of age-related tissue microenvironments. The evidence discussed here suggests that while the riddle of whether epigenetics drives microenvironmental changes, or whether changes in the microenvironment alter heritable cellular memory has not been solved, a path has been cleared enabling functional analysis leading to the prediction of key nodes in the network that link the microenvironment with the epigenome. The hypothesis that the accumulation of somatic mutations with age drives the age-related increase in breast cancer incidence, if correct, has a somewhat nihilistic conclusion, namely that cancers will be impossible to avoid. Alternatively, if microenvironment-driven epigenetic changes are the key to explaining susceptibility to age-related breast cancers, then there is hope that primary prevention is possible because epigenomes are relatively malleable.
© 2015 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26539838      PMCID: PMC4860162          DOI: 10.1159/000441030

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  63 in total

1.  Age-related lobular involution and risk of breast cancer.

Authors:  Tia R Milanese; Lynn C Hartmann; Thomas A Sellers; Marlene H Frost; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; Amy C Degnim; Celine M Vachon; Carol A Reynolds; Romayne A Thompson; L Joseph Melton; Ellen L Goode; Daniel W Visscher
Journal:  J Natl Cancer Inst       Date:  2006-11-15       Impact factor: 13.506

2.  Tandem-base mutations occur in mouse liver and adipose tissue preferentially as G:C to T:A transversions and accumulate with age.

Authors:  V L Buettner; K A Hill; A Halangoda; S S Sommer
Journal:  Environ Mol Mutagen       Date:  1999       Impact factor: 3.216

3.  Only three driver gene mutations are required for the development of lung and colorectal cancers.

Authors:  Cristian Tomasetti; Luigi Marchionni; Martin A Nowak; Giovanni Parmigiani; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

4.  Biologic markers determine both the risk and the timing of recurrence in breast cancer.

Authors:  Laura J Esserman; Dan H Moore; Pamela J Tsing; Philip W Chu; Christina Yau; Elissa Ozanne; Robert E Chung; Vickram J Tandon; John W Park; Frederick L Baehner; Stig Kreps; Andrew N J Tutt; Cheryl E Gillett; Christopher C Benz
Journal:  Breast Cancer Res Treat       Date:  2011-05-20       Impact factor: 4.872

5.  Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.

Authors:  A A Howeedy; I Virtanen; L Laitinen; N S Gould; G K Koukoulis; V E Gould
Journal:  Lab Invest       Date:  1990-12       Impact factor: 5.662

6.  The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia.

Authors:  A W Stoker; C Hatier; M J Bissell
Journal:  J Cell Biol       Date:  1990-07       Impact factor: 10.539

7.  Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.

Authors:  Federica Sotgia; Francesco Del Galdo; Mathew C Casimiro; Gloria Bonuccelli; Isabelle Mercier; Diana Whitaker-Menezes; Kristin M Daumer; Jie Zhou; Chenguang Wang; Sanjay Katiyar; Huan Xu; Emily Bosco; Andrew A Quong; Bruce Aronow; Agnieszka K Witkiewicz; Carlo Minetti; Philippe G Frank; Sergio A Jimenez; Erik S Knudsen; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

Review 8.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

9.  Loss of caveolin-1 accelerates neurodegeneration and aging.

Authors:  Brian P Head; Jason N Peart; Mathivadhani Panneerselvam; Takaakira Yokoyama; Matthew L Pearn; Ingrid R Niesman; Jacqueline A Bonds; Jan M Schilling; Atsushi Miyanohara; John Headrick; Sameh S Ali; David M Roth; Piyush M Patel; Hemal H Patel
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

10.  Transcriptional profiling of aging in human muscle reveals a common aging signature.

Authors:  Jacob M Zahn; Rebecca Sonu; Hannes Vogel; Emily Crane; Krystyna Mazan-Mamczarz; Ralph Rabkin; Ronald W Davis; Kevin G Becker; Art B Owen; Stuart K Kim
Journal:  PLoS Genet       Date:  2006-06-09       Impact factor: 5.917

View more
  20 in total

1.  Cell and Tissue Biology Paves a Path to Breast Cancer Prevention.

Authors:  Michael E Todhunter; Mark A LaBarge
Journal:  Trends Cancer       Date:  2017-04-18

Review 2.  Recent Advances in Experimental Models of Breast Cancer Exosome Secretion, Characterization and Function.

Authors:  Fanny A Pelissier Vatter; Serena Lucotti; Haiying Zhang
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-12-22       Impact factor: 2.673

3.  The promise of single-cell mechanophenotyping for clinical applications.

Authors:  Molly Kozminsky; Lydia L Sohn
Journal:  Biomicrofluidics       Date:  2020-06-09       Impact factor: 2.800

4.  A human breast atlas integrating single-cell proteomics and transcriptomics.

Authors:  G Kenneth Gray; Carman Man-Chung Li; Jennifer M Rosenbluth; Laura M Selfors; Nomeda Girnius; Jia-Ren Lin; Ron C J Schackmann; Walter L Goh; Kaitlin Moore; Hana K Shapiro; Shaolin Mei; Kurt D'Andrea; Katherine L Nathanson; Peter K Sorger; Sandro Santagata; Aviv Regev; Judy E Garber; Deborah A Dillon; Joan S Brugge
Journal:  Dev Cell       Date:  2022-05-25       Impact factor: 13.417

Review 5.  Tissue aging: the integration of collective and variant responses of cells to entropic forces over time.

Authors:  Michael E Todhunter; Rosalyn W Sayaman; Masaru Miyano; Mark A LaBarge
Journal:  Curr Opin Cell Biol       Date:  2018-06-19       Impact factor: 8.382

6.  MiR-539 inhibits proliferation and migration of triple-negative breast cancer cells by down-regulating LAMA4 expression.

Authors:  Zhi-Xue Yang; Bo Zhang; Jinrong Wei; Guo-Qin Jiang; Yan-Lin Wu; Bing-Jing Leng; Chun-Gen Xing
Journal:  Cancer Cell Int       Date:  2018-01-30       Impact factor: 5.722

7.  Tracing anti-cancer and cancer-promoting actions of all-trans retinoic acid in breast cancer to a RARα epigenetic mechanism of mammary epithelial cell fate.

Authors:  Stefano Rossetti; MingQiang Ren; Nicolo Visconti; Francesca Corlazzoli; Vincenzo Gagliostro; Giulia Somenzi; Jin Yao; Yijun Sun; Nicoletta Sacchi
Journal:  Oncotarget       Date:  2016-12-27

Review 8.  Splicing alterations in healthy aging and disease.

Authors:  Brittany Lynn Angarola; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-02-09       Impact factor: 9.957

9.  miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7.

Authors:  Liquan Hong; Feng Pan; Huifen Jiang; Lahong Zhang; Yuhua Liu; Chengsong Cai; Chunzhen Hua; Xian Luo; Jinhua Sun; Zhaojun Chen
Journal:  Onco Targets Ther       Date:  2016-05-04       Impact factor: 4.147

10.  Pathobiology of the 129:Stat1 -/- mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotype.

Authors:  Hidetoshi Mori; Jane Q Chen; Robert D Cardiff; Zsófia Pénzváltó; Neil E Hubbard; Louis Schuetter; Russell C Hovey; Josephine F Trott; Alexander D Borowsky
Journal:  Breast Cancer Res       Date:  2017-09-02       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.